NCT02524821View on ClinicalTrials.gov

The Effect of Gelesis100 on the Pharmacokinetics of Metformin

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy Overweight Obese
Interventions
DEVICE

Gelesis100

3 capsules each containing 0.75 mg

DRUG

Metformin

1 tablet of 850 mg

Trial Locations (1)

Unknown

Québec

Sponsors

Lead Sponsor

Gelesis, Inc.
All Listed Sponsors
lead

Gelesis, Inc.

INDUSTRY

NCT02524821 - The Effect of Gelesis100 on the Pharmacokinetics of Metformin | Biotech Hunter | Biotech Hunter